Cardiome Oxyprim “Approvable” For Gout, But Product’s Future Now In Doubt

FDA requests additional clinical and manufacturing data. Cardiome will “reflect” on FDA’s comments before making a final decision on oxypurinol.

More from Archive

More from Pink Sheet